(S (S (NP (NNP Neuroblastoma)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB strongly) (JJ heterogeneous)) (NN cancer)) (PP (IN with) (NP (NP (ADJP (RB very) (JJ diverse)) (JJ clinical) (NNS courses)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB vary) (PP (PP (IN from) (NP (JJ spontaneous) (NN regression))) (PP (TO to) (NP (JJ fatal) (NN progression))))))))))))) (: ;) (S (NP (NP (NP (DT an) (JJ accurate) (NN patient) (POS 's)) (NN risk) (NN estimation)) (PP (IN at) (NP (NN diagnosis)))) (VP (VBZ is) (ADJP (JJ essential) (S (VP (TO to) (VP (VB design) (NP (JJ appropriate) (NN tumor) (NN treatment) (NNS strategies)))))))) (. .))
(S (NP (NNP Neuroblastoma)) (VP (VBZ is) (NP (NP (DT a) (JJ paradigm) (NN disease)) (SBAR (WHADVP (WRB where)) (S (NP (JJ different) (JJ diagnostic) (CC and) (JJ prognostic) (NNS endpoints)) (VP (MD should) (VP (VB be) (VP (VBN predicted) (PP (IN from) (NP (JJ common) (ADJP (NN molecular) (CC and) (JJ clinical)) (NN information))) (, ,) (PP (IN with) (NP (VBG increasing) (NN complexity))) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (DT the) (NNP FDA) (NNP MAQC-II) (NN study))))))))))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP introduce) (NP (NP (DT the) (JJ novel) (JJ multiobjective) (NN deep) (NN learning) (NN architecture)) (NP (NP (NNP CDRP)) (PRN (-LRB- -LRB-) (NP (NNP Concatenated) (NNP Diagnostic) (NNP Relapse) (NNP Prognostic)) (-RRB- -RRB-))) (VP (VBN composed) (PP (IN by) (NP (CD 8) (NNS layers))) (S (VP (TO to) (VP (VB obtain) (NP (DT a) (JJ combined) (ADJP (JJ diagnostic) (CC and) (JJ prognostic)) (NN prediction)) (PP (IN from) (NP (JJ high-throughput) (NNS transcriptomics) (NNS data))))))))) (. .))
(S (NP (CD Two) (JJ distinct) (NN loss) (NNS functions)) (VP (VBP are) (VP (VBN optimized) (PP (IN for) (NP (NP (DT the) (NX (NNP Event) (NNP Free) (NNP Survival) (PRN (-LRB- -LRB-) (NP (NNP EFS)) (-RRB- -RRB-))) (CC and) (NX (JJ Overall) (NNP Survival) (PRN (-LRB- -LRB-) (NP (NNP OS)) (-RRB- -RRB-))) (NN prognosis)) (, ,) (ADVP (RB respectively)))))) (. .))
(S (NP (PRP We)) (VP (VBP use) (NP (DT the) (NNP High-Risk) (PRN (-LRB- -LRB-) (NNP HR) (-RRB- -RRB-)) (JJ diagnostic) (NN information)) (PP (IN as) (NP (NP (DT an) (JJ additional) (NN input)) (VP (VBN generated) (PP (IN by) (NP (DT an) (NN autoencoder) (NN embedding))))))) (. .))
(S (NP (DT The) (NN latter)) (VP (VBZ is) (VP (VBN used) (PP (IN as) (NP (NN network) (NN regulariser))) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (DT a) (JJ clinical) (NN algorithm)) (VP (ADVP (RB commonly)) (VBD adopted) (PP (IN for) (S (VP (VBG stratifying) (NP (NNS patients)) (PP (IN from) (NP (NP (NN cancer) (NN stage)) (, ,) (NP (NP (NN age)) (PP (IN at) (NP (NP (NN insurgence)) (PP (IN of) (NP (NN disease)))))) (, ,) (CC and) (NP (NP (NNP MYCN)) (, ,) (NP (DT the) (JJ specific) (JJ molecular) (NN marker)))))))))))))) (. .))
(S (NP (DT The) (NN architecture)) (VP (VBD was) (VP (VBN applied) (PP (TO to) (NP (NNP Illumina) (NNP HiSeq2000) (NNP RNA-Seq))) (PP (IN for) (NP (NP (CD 498) (JJ neuroblastoma) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 176)) (PP (IN at) (NP (JJ high) (NN risk)))) (-RRB- -RRB-)) (PP (IN from) (NP (DT the) (NNP Sequencing) (NNP Quality) (NNP Control) (PRN (-LRB- -LRB-) (NNP SEQC) (-RRB- -RRB-)) (NN study))))) (, ,) (S (VP (VP (VBG obtaining) (NP (NP (NN state-of-art)) (PP (IN on) (NP (DT the) (JJ diagnostic) (NN endpoint))))) (CC and) (VP (VBG improving) (NP (NP (NN prediction)) (PP (IN of) (NP (NN prognosis))) (PP (IN over) (NP (DT the) (NNP HR) (NN cohort))))))))) (. .))
